Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pacher

Showing results (21-30 of 1,015) with videos related to

Pageof 102
Sort By:
European Journal of Heart Failure|August 10, 2000
Ambulatory vasodilator therapy in heart failure: systematic review of the literature and personal observational experienceR Pacher, B Stanek
Physical Review. D, Particles and Fields|September 15, 1987
Can bulk viscosity drive inflation?Pacher, Stein-Schabes, Turner
Journal of Leukocyte Biology|December 28, 2007
A2A receptors in inflammation and injury: lessons learned from transgenic animalsGyörgy Haskó, Pál Pacher
American Journal of Physiology. Gastrointestinal and Liver Physiology|February 2, 2008
Endocannabinoids and liver disease. III. Endocannabinoid effects on immune cells: implications for inflammatory liver diseasesPál Pacher, Bin Gao
Circulation|April 10, 2002
Use of selective serotonin reuptake inhibitors and myocardial infarctionPal Pacher, Zoltan Ungvari
British Journal of Pharmacology|November 21, 2007
Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioningP Pacher, G Haskó
Seminars in Immunopathology|April 10, 2009
The emerging role of the endocannabinoid system in cardiovascular diseasePál Pacher, Sabine Steffens
American Journal of Physiology. Heart and Circulatory Physiology|May 18, 2010
Endothelial Nrf2 activation: a new target for resveratrol?György Haskó, Pál Pacher
Wiener Klinische Wochenschrift|January 1, 1996
Prostaglandin E1 in heart failure: the Vienna experienceR Pacher, B Stanek
Science Translational Medicine|August 10, 2012
The outsiders: emerging roles of ectonucleotidases in inflammationCsaba Szabo, Pal Pacher
Pageof 102

Showing results (21-30 of 1,015) with videos related to

Sort By:
Pageof 102
European Journal of Heart Failure|August 10, 2000
Ambulatory vasodilator therapy in heart failure: systematic review of the literature and personal observational experienceR Pacher, B Stanek
Physical Review. D, Particles and Fields|September 15, 1987
Can bulk viscosity drive inflation?Pacher, Stein-Schabes, Turner
Journal of Leukocyte Biology|December 28, 2007
A2A receptors in inflammation and injury: lessons learned from transgenic animalsGyörgy Haskó, Pál Pacher
American Journal of Physiology. Gastrointestinal and Liver Physiology|February 2, 2008
Endocannabinoids and liver disease. III. Endocannabinoid effects on immune cells: implications for inflammatory liver diseasesPál Pacher, Bin Gao
Circulation|April 10, 2002
Use of selective serotonin reuptake inhibitors and myocardial infarctionPal Pacher, Zoltan Ungvari
British Journal of Pharmacology|November 21, 2007
Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioningP Pacher, G Haskó
Seminars in Immunopathology|April 10, 2009
The emerging role of the endocannabinoid system in cardiovascular diseasePál Pacher, Sabine Steffens
American Journal of Physiology. Heart and Circulatory Physiology|May 18, 2010
Endothelial Nrf2 activation: a new target for resveratrol?György Haskó, Pál Pacher
Wiener Klinische Wochenschrift|January 1, 1996
Prostaglandin E1 in heart failure: the Vienna experienceR Pacher, B Stanek
Science Translational Medicine|August 10, 2012
The outsiders: emerging roles of ectonucleotidases in inflammationCsaba Szabo, Pal Pacher
Pageof 102